Elisabetta Rovida

14PUBLICATIONS
31CO-AUTHORS
Clinical pharmacology and therapeuticsPredictive and prognostic markersMolecular targetsEnvironmental epidemiologyFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 13, 2025
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer?

Alessandro Tubita, Dimitri Papini, Ignazia Tusa

|Feb 25, 2025
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

Ignazia Tusa, Sinforosa Gagliardi, Alessio Menconi

|Jul 05, 2024
Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.

Zoe Lombardi, Lucia Gardini, Anatolii V Kashchuk

|Jun 30, 2023
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation.

Isabelle Seidita, Ignazia Tusa, Matteo Prisinzano

|May 16, 2023
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.

Ignazia Tusa, Alessio Menconi, Alessandro Tubita

|May 28, 2022
Targeting MAPK in Cancer 2.0.

Elisabetta Rovida, Ignazia Tusa

Pageof 3

Frequent Collaborators

7 joint publications

Ignazia Tusa

4 joint publications

Barbara Stecca

4 joint publications

Matteo Lulli

3 joint publications

Persio Dello Sbarba